Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset

NATerminatedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2015

Conditions
Depression, Postpartum
Interventions
DEVICE

NeuroStar Transcranial Magnetic Stimulation (TMS)

"Acute phase: 120% of observed MT, 10 pulses per second, 4 second on-time, 26 second off-time, 75 trains, 3,000 total pulses/session, five times weekly for up to 8 weeks.~3 week taper phase: 120% of observed MT, 10 pulses per second, 4 second on-time, 26 second off-time, 75 trains, 3,000 total pulses/session, 3 times during the first week, 2 times during the second week and one time during the third week. In addition to treatments, patients may receive treatment as usual at the direction of their treating physician."

Trial Locations (8)

10022

TMS Medical Associates of NY, New York

18104

TMS Center of Lehigh Valley, Allentown

32502

Harmonex Neuroscience and Research of Pensacola, Pensacola

32606

UF Health Adult Psychiatry - Springhill, Gainesville

40222

Integrative Psychiatry, Louisville

60612

Rush University Medical Center, Chicago

84108

University of Utah - Neuropsychiatric Institute, Salt Lake City

06102

Hartford Hospital Institute of Living, Hartford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Neuronetics

OTHER